Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I J Heuser

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Neurology|November 1, 1989
Rationale for continuous dopaminomimetic therapy of Parkinson's diseaseT N Chase, F Baronti, G Fabbrini, et al.
Neurobiology of Aging|March 1, 1994
Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of genderI J Heuser, U Gotthardt, U Schweiger, et al.
Biological Psychiatry|December 15, 1995
Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: IIC H Lammers, D Garcia-Borreguero, J Schmider, et al.
Annals of Neurology|October 1, 1991
Somatostatin replacement therapy for Alzheimer dementiaM M Mouradian, J Blin, M Giuffra, et al.
The American Journal of Psychiatry|January 1, 1996
Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjectsI J Heuser, U Schweiger, U Gotthardt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1991
Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's diseaseM M Mouradian, I J Heuser, F Baronti, et al.
Neurobiology of Aging|March 1, 1992
Growth hormone secretion in Alzheimer's disease: 24-hour profile of basal levels and response to stimulation and suppression studiesI J Heuser, F Baronti, C A Marin, et al.
Neuroscience Letters|October 23, 1989
No changes in central quinolinic acid levels in Alzheimer's diseaseM M Mourdian, M P Heyes, J B Pan, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Neurology|November 1, 1989
Rationale for continuous dopaminomimetic therapy of Parkinson's diseaseT N Chase, F Baronti, G Fabbrini, et al.
Neurobiology of Aging|March 1, 1994
Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of genderI J Heuser, U Gotthardt, U Schweiger, et al.
Biological Psychiatry|December 15, 1995
Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: IIC H Lammers, D Garcia-Borreguero, J Schmider, et al.
Annals of Neurology|October 1, 1991
Somatostatin replacement therapy for Alzheimer dementiaM M Mouradian, J Blin, M Giuffra, et al.
The American Journal of Psychiatry|January 1, 1996
Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjectsI J Heuser, U Schweiger, U Gotthardt, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1991
Comparison of the clinical pharmacology of (-)NPA and levodopa in Parkinson's diseaseM M Mouradian, I J Heuser, F Baronti, et al.
Neurobiology of Aging|March 1, 1992
Growth hormone secretion in Alzheimer's disease: 24-hour profile of basal levels and response to stimulation and suppression studiesI J Heuser, F Baronti, C A Marin, et al.
Neuroscience Letters|October 23, 1989
No changes in central quinolinic acid levels in Alzheimer's diseaseM M Mourdian, M P Heyes, J B Pan, et al.
Pageof 2